Murray Stahl’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.7M | Buy |
283,774
+13,521
| +5% | +$3.74M | 0.71% | 20 |
|
|
2026
Q1 | $79.8M | Sell |
270,253
-5,358
| -2% | -$1.59M | 0.86% | 16 |
|
|
2025
Q4 | $75.3M | Sell |
275,611
-1,162
| -0.4% | -$316K | 1.02% | 16 |
|
|
2025
Q3 | $74.8M | Buy |
276,773
+149,375
| +117% | +$40.6M | 0.91% | 16 |
|
|
2025
Q2 | $35.1M | Sell |
127,398
-855
| -0.7% | -$233K | 0.42% | 25 |
|
|
2025
Q1 | $34M | Buy |
128,253
+2,400
| +2% | +$592K | 0.39% | 25 |
|
|
2024
Q4 | $29.2M | Sell |
125,853
-2,860
| -2% | -$658K | 0.36% | 28 |
|
|
2024
Q3 | $28.4M | Sell |
128,713
-11,899
| -8% | -$2.46M | 0.43% | 26 |
|
|
2024
Q2 | $27.6M | Sell |
140,612
-58,788
| -29% | -$12.1M | 0.48% | 24 |
|
|
2024
Q1 | $42.9M | Sell |
199,400
-1,330
| -0.7% | -$279K | 0.81% | 16 |
|
|
2023
Q4 | $42.3M | Sell |
200,730
-19,246
| -9% | -$4.11M | 0.89% | 18 |
|
|
2023
Q3 | $44M | Sell |
219,976
-11,451
| -5% | -$2.28M | 0.87% | 15 |
|
|
2023
Q2 | $42.9M | Sell |
231,427
-9,160
| -4% | -$1.69M | 0.92% | 22 |
|
|
2023
Q1 | $46.1M | Sell |
240,587
-4,087
| -2% | -$739K | 0.88% | 19 |
|
|
2022
Q4 | $41.1M | Sell |
244,674
-7,488
| -3% | -$1.3M | 0.68% | 23 |
|
|
2022
Q3 | $44.7M | Sell |
252,162
-11,987
| -5% | -$2.37M | 0.9% | 18 |
|
|
2022
Q2 | $54.1M | Buy |
264,149
+18,474
| +8% | +$3.92M | 1.13% | 14 |
|
|
2022
Q1 | $58.4M | Buy |
245,675
+34,753
| +16% | +$8.16M | 1.18% | 15 |
|
|
2021
Q4 | $48.2M | Buy |
210,922
+8,798
| +4% | +$1.94M | 1.06% | 17 |
|
|
2021
Q3 | $39.1M | Buy |
202,124
+2,008
| +1% | +$407K | 0.91% | 20 |
|
|
2021
Q2 | $42.6M | Buy |
200,116
+39,478
| +25% | +$8.34M | 0.87% | 17 |
|
|
2021
Q1 | $32.8M | Buy |
160,638
+7,738
| +5% | +$1.52M | 0.74% | 21 |
|
|
2020
Q4 | $27.8M | Sell |
152,900
-18,164
| -11% | -$3.09M | 0.93% | 22 |
|
|
2020
Q3 | $28.6M | Sell |
171,064
-11,541
| -6% | -$1.94M | 1.15% | 17 |
|
|
2020
Q2 | $29.7M | Sell |
182,605
-5,838
| -3% | -$1.05M | 1.07% | 18 |
|
|
2020
Q1 | $32.6M | Sell |
188,443
-7,972
| -4% | -$1.59M | 1.44% | 18 |
|
|
2019
Q4 | $39.4M | Sell |
196,415
-8,211
| -4% | -$1.68M | 1.12% | 17 |
|
|
2019
Q3 | $43.2M | Sell |
204,626
-3,637
| -2% | -$760K | 1.3% | 17 |
|
|
2019
Q2 | $40.4M | Sell |
208,263
-9,563
| -4% | -$1.76M | 1.12% | 18 |
|
|
2019
Q1 | $35.9M | Buy |
+217,826
| New | +$38.5M | 1% | 19 |
|
Other funds holding CME
Murray Stahl's CME Position: Q2 2026 in Review
Murray Stahl increased its CME Group (CME) stake by 5% in Q2 2026, buying an estimated $3.74M and bringing the position to 283,774 shares worth $62.7M. The position accounts for 0.71% of the portfolio, ranked #20.
Murray Stahl first reported a position in CME in Q1 2019 and has held it in 30 quarters since. The position peaked at $79.8M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Murray Stahl held 283,774 shares of CME Group worth $62.7M as of Q2 2026.
- Murray Stahl bought 13,521 CME Group shares in Q2 2026, an estimated $3.74M.
- CME Group made up 0.71% of Murray Stahl's portfolio in Q2 2026, its #20 holding.
- Murray Stahl first reported a position in CME Group in Q1 2019 and has held it in 30 quarters since.
- Murray Stahl's CME Group position peaked at $79.8M in Q1 2026.
- 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.